Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$9.60
+4.29%
Mkt Cap $1.46B
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
Implied Upside
+87.6%
Consensus $18.00 vs current $9.60
NASDAQ·Healthcare·Biotechnology
$9.60
+4.29%
Mkt Cap $1.46B
Buy
3
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
+87.6%
Consensus $18.00 vs current $9.60